Skip to main content
Clinical Trials/NL-OMON22294
NL-OMON22294
Recruiting
Not Applicable

The influence of supplementary regional anesthesia with ropivacaine on postoperative pain, nausea and vomiting in patients undergoing mamma surgery under general anesthesia (SUPREMA trial).

.P.TanApotheek Reinier de Graaf Groep DelftPostbus 50112600 GA Delftvtan@rdgg.nlNo sponsors0 sites150 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
.P.TanApotheek Reinier de Graaf Groep DelftPostbus 50112600 GA Delftvtan@rdgg.nlNo sponsors
Enrollment
150
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
.P.TanApotheek Reinier de Graaf Groep DelftPostbus 50112600 GA Delftvtan@rdgg.nlNo sponsors

Eligibility Criteria

Inclusion Criteria

  • 2\. One\-sided breast conserving surgery with or without sentinel node biopsy;

Exclusion Criteria

  • 1\. Known allergy to amide type local anesthetics;
  • 2\. Severe liver failure;

Outcomes

Primary Outcomes

Not specified

Similar Trials